These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11788236)

  • 1. GSK-3 and the neurodevelopmental hypothesis of schizophrenia.
    Kozlovsky N; Belmaker RH; Agam G
    Eur Neuropsychopharmacol; 2002 Feb; 12(1):13-25. PubMed ID: 11788236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Schizophrenia, neurodevelopment and glycogen synthase kinase-3].
    Nadri C; Kozlovsky N; Agam G
    Harefuah; 2003 Sep; 142(8-9):636-42, 644. PubMed ID: 14518171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tcf-1-mediated transcription in T lymphocytes: differential role for glycogen synthase kinase-3 in fibroblasts and T cells.
    Staal FJ; Burgering BM; van de Wetering M; Clevers HC
    Int Immunol; 1999 Mar; 11(3):317-23. PubMed ID: 10221643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low GSK-3 activity in frontal cortex of schizophrenic patients.
    Kozlovsky N; Belmaker RH; Agam G
    Schizophr Res; 2001 Oct; 52(1-2):101-5. PubMed ID: 11595396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen synthase kinase-3beta immunoreactivity is reduced in the prefrontal cortex in schizophrenia.
    Beasley C; Cotter D; Khan N; Pollard C; Sheppard P; Varndell I; Lovestone S; Anderton B; Everall I
    Neurosci Lett; 2001 Apr; 302(2-3):117-20. PubMed ID: 11290401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.
    Ikeda S; Kishida S; Yamamoto H; Murai H; Koyama S; Kikuchi A
    EMBO J; 1998 Mar; 17(5):1371-84. PubMed ID: 9482734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low GSK-3beta immunoreactivity in postmortem frontal cortex of schizophrenic patients.
    Kozlovsky N; Belmaker RH; Agam G
    Am J Psychiatry; 2000 May; 157(5):831-3. PubMed ID: 10784483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo activation and nuclear translocation of phosphorylated glycogen synthase kinase-3beta in neuronal apoptosis: links to tau phosphorylation.
    Elyaman W; Terro F; Wong NS; Hugon J
    Eur J Neurosci; 2002 Feb; 15(4):651-60. PubMed ID: 11886446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of alanyl-aminopeptidase suppresses the activation-dependent induction of glycogen synthase kinase-3beta (GSK-3beta) in human T cells.
    Lendeckel U; Scholz B; Arndt M; Frank K; Spiess A; Chen H; Roques BP; Ansorge S
    Biochem Biophys Res Commun; 2000 Jun; 273(1):62-5. PubMed ID: 10873564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schizophrenia as a GSK-3 dysregulation disorder.
    Lovestone S; Killick R; Di Forti M; Murray R
    Trends Neurosci; 2007 Apr; 30(4):142-9. PubMed ID: 17324475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of glycogen synthase kinase 3 beta (GSK-3beta) by platelet activating factor mediates migration and cell death in cerebellar granule neurons.
    Tong N; Sanchez JF; Maggirwar SB; Ramirez SH; Guo H; Dewhurst S; Gelbard HA
    Eur J Neurosci; 2001 May; 13(10):1913-22. PubMed ID: 11403684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3.
    Christian SL; Sims PV; Gold MR
    J Immunol; 2002 Jul; 169(2):758-69. PubMed ID: 12097378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45.
    Hagen T; Vidal-Puig A
    Biochem Biophys Res Commun; 2002 Jun; 294(2):324-8. PubMed ID: 12051714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patients.
    Nadri C; Dean B; Scarr E; Agam G
    Schizophr Res; 2004 Dec; 71(2-3):377-82. PubMed ID: 15474909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium butyrate-induced differentiation of human LIM2537 colon cancer cells decreases GSK-3beta activity and increases levels of both membrane-bound and Apc/axin/GSK-3beta complex-associated pools of beta-catenin.
    Vincan E; Leet CS; Reyes NI; Dilley RJ; Thomas RJ; Phillips WA
    Oncol Res; 2000; 12(4):193-201. PubMed ID: 11341469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level.
    Nakamura T; Hamada F; Ishidate T; Anai K; Kawahara K; Toyoshima K; Akiyama T
    Genes Cells; 1998 Jun; 3(6):395-403. PubMed ID: 9734785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposing actions of phosphatidylinositol 3-kinase and glycogen synthase kinase-3beta in the regulation of HSF-1 activity.
    Bijur GN; Jope RS
    J Neurochem; 2000 Dec; 75(6):2401-8. PubMed ID: 11080191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3beta transgenes.
    Brownlees J; Irving NG; Brion JP; Gibb BJ; Wagner U; Woodgett J; Miller CC
    Neuroreport; 1997 Oct; 8(15):3251-5. PubMed ID: 9351652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells.
    Fishman P; Madi L; Bar-Yehuda S; Barer F; Del Valle L; Khalili K
    Oncogene; 2002 Jun; 21(25):4060-4. PubMed ID: 12037688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental expression and localization of glycogen synthase kinase-3beta in rat brain.
    Leroy K; Brion JP
    J Chem Neuroanat; 1999 Jun; 16(4):279-93. PubMed ID: 10450875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.